Effects of sitagliptin on intrahepatic lipid content in patients with non-alcoholic fatty liver disease

PURPOSE: Dipeptidyl peptidase-4 inhibitors (DPP-4I), key regulators of the actions of incretin hormones, exert anti-hyperglycemic effects in type 2 diabetes mellitus (T2DM) patients. A major unanswered question concerns the potential ability of DPP-4I to improve intrahepatic lipid (IHL) content in n...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xingchun, Zhao, Bangfeng, Sun, Hang, You, Hui, Qu, Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441565/
https://www.ncbi.nlm.nih.gov/pubmed/36072931
http://dx.doi.org/10.3389/fendo.2022.866189

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9441565/
https://www.ncbi.nlm.nih.gov/pubmed/36072931
http://dx.doi.org/10.3389/fendo.2022.866189

Ejemplares similares